Recorded active ingredients: Ciprofloxacin
Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.
Travellers familiar with Cipro from one market are not always certain to find the same brand abroad — it is registered in nine countries, a footprint that is narrower than many readers assume given how recognisable the name has become. Cipro contains the active ingredient ciprofloxacin, classified as a broad-spectrum bactericidal antibacterial.
Ciprofloxacin is prescribed across a wide range of bacterial infections, including urinary tract infections, certain types of pneumonia, gonorrhoea, peritonitis, sepsis, prostatitis, and keratitis, among other indications. The structured section further down this page lists the registered uses recognised in the markets where Cipro is sold. Because the active ingredient sits in a well-established antibacterial class, it is encountered in clinical practice on every continent — even where this particular brand is not on the shelf.
The Cipro brand specifically is registered in countries spread across several regions rather than concentrated in one cluster: examples include Brazil, Canada, Egypt, Turkey, and Georgia. A traveller arriving in a country outside this list is unlikely to find Cipro by name but very likely to find ciprofloxacin under another brand or as a generic, since the molecule is among the most widely manufactured antibacterials in the world.
Other antibacterial agents in adjacent classes are also available internationally, but antibiotic selection is not interchangeable — choice of agent depends on the specific infection, local resistance patterns, and patient factors that only a clinician can weigh. A local pharmacist can help identify a ciprofloxacin-containing product in the destination country, while decisions about whether ciprofloxacin is the right antibiotic for a given situation should be made with a healthcare provider familiar with the case.
These listings match the full ingredient set recorded for Cipro. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.
Cipro is prescribed for a range of bacterial infections, including urinary tract infections, certain pneumonias, gonorrhoea, peritonitis, sepsis, prostatitis, and keratitis. Its active ingredient is classed as a broad-spectrum bactericidal antibacterial, meaning it is positioned for use against a wide group of susceptible bacteria. The structured indication block further down this page details each registered use in the markets where Cipro is sold.
Cipro contains ciprofloxacin, a broad-spectrum bactericidal antibacterial. Ciprofloxacin is one of the most widely manufactured antibacterials in the world and circulates internationally under a number of brand names as well as generic versions. The molecule itself is the same regardless of the commercial label on the packaging, although available strengths and formulations vary between regulatory regimes.
The Cipro brand is registered in nine countries, with examples including Brazil, Canada, Egypt, Turkey, Colombia, Georgia, and the United States. The footprint spans several regions rather than a single cluster. If your country is not represented on this list, ciprofloxacin is very likely available locally under another brand name or as a generic — a local pharmacist can confirm what is on the market.
Ciprofloxacin is sold internationally under several brand names and as a generic in most regulated markets, so the same active ingredient is widely accessible even where the Cipro brand is not. Other antibacterials in adjacent classes also exist, but antibiotics are not freely interchangeable — choice of agent depends on the infection and local resistance patterns. To find a local ciprofloxacin product, search the active ingredient on Pill2Trip or ask a pharmacist.
Yes. Cipro is a prescription antibacterial in the markets where it is registered, and antibiotic selection is highly dependent on the specific infection, the patient's clinical situation, and local resistance patterns that vary considerably between countries. Travellers and expatriates should not self-substitute antibiotics across borders. Any decision to start, continue, or change ciprofloxacin therapy needs to involve a healthcare provider familiar with the case.
